MeghanJude(Campo)MooradianMD

PubMed

• 65 citations
  Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
  Sara Valpione, Matteo S. Carlino, J. Mangana, Meghan J. Mooradian, Grant A. McArthur
  European Journal of Cancer. 2018-03-01
• 24 citations
  Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
  F Dimitriou, K Namikawa, I L M Reijers, E I Buchbinder, J A Soon
  Annals of Oncology. 2022-09-01
• 772 citations
  The Effect of Advances in Lung-Cancer Treatment on Population Mortality
  Nadia Howlader, Gonçalo Forjaz, Meghan J. Mooradian, Rafael Meza, Chung Yin Kong
  The New England Journal of Medicine. 2020-08-12

Journal Articles

• Differential Expression of PD-L1 and IDO1 in Association with the Immune Microenvironment in Resected Lung Adenocarcinomas  
  M Lisa Zhang, Justin F Gainor, Meghan J Mooradian, Nature
• Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer.  
  Meghan Campo, Hani Al-Halabi, Melin Khandekar, Alice T Shaw, Lecia V Sequist, Henning Willers, Oncologist, 6/27/2016
• Hemophagocytic Lymphohistiocytosis in Adults.  
  Meghan Campo, Nancy Berliner, Hematol. Oncol. Clin. North Am., 10/2015
• Safety and outcome of patients treated with a modified outpatient intraperitoneal regimen for epithelial ovarian, primary peritoneal or fallopian tube cancer  
  Chiara Battelli, Meghan Campo, Mary K Buss, Christopher S Awtrey, Panagiotis A Konstantinopoulos, Chemotherapy, 2013
• Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.  
  Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, Robert C Doebele, Edward Garon, David E Gerber, Sarah B Goldberg, Peter S Hammerman, Rebecca S Heist, Thomas H..., Journal of Thoracic Oncology, 1/2010
• Join now to see all

Lectures

• A phase II study of cryoablation (cryo) of an enlarging tumor in patients (pts) with advanced lung cancer or melanoma receiving post-progression immune checkpoint inhi... 
  2019 ASCO Annual Meeting - 6/1/2019